• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因表达谱与癌症相关途径与孕激素受体异构体 A(PRA)在转基因小鼠乳腺中的优势相关。

Gene expression profile and cancer-associated pathways linked to progesterone receptor isoform a (PRA) predominance in transgenic mouse mammary glands.

机构信息

Discipline of Oncology, Department of Radiology and Oncology, Faculty of Medicine, University of São Paulo, São Paulo, SP, 01246-903, Brazil.

Laboratory of Molecular Genetics, Center for Translational Research in Oncology, Cancer Institute of São Paulo, São Paulo, SP, 01246-000, Brazil.

出版信息

BMC Cancer. 2018 Jun 25;18(1):682. doi: 10.1186/s12885-018-4550-z.

DOI:10.1186/s12885-018-4550-z
PMID:29940887
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6019805/
Abstract

BACKGROUND

Progesterone receptor (PR) is expressed from a single gene as two isoforms, PRA and PRB. In normal breast human tissue, PRA and PRB are expressed in equimolar ratios, but isoform ratio is altered during malignant progression, usually leading to high PRA:PRB ratios. We took advantage of a transgenic mouse model where PRA isoform is predominant (PRA transgenics) and identified the key transcriptional events and associated pathways underlying the preneoplastic phenotype in mammary glands of PRA transgenics as compared with normal wild-type littermates.

METHODS

The transcriptomic profiles of PRA transgenics and wild-type mammary glands were generated using microarray technology. We identified differentially expressed genes and analyzed clustering, gene ontology (GO), gene set enrichment analysis (GSEA), and pathway profiles. We also performed comparisons with publicly available gene expression data sets of human breast cancer.

RESULTS

We identified a large number of differentially expressed genes which were mainly associated with metabolic pathways for the PRA transgenics phenotype while inflammation- related pathways were negatively correlated. Further, we determined a significant overlap of the pathways characterizing PRA transgenics and those in breast cancer subtypes Luminal A and Luminal B and identified novel putative biomarkers, such as PDHB and LAMB3.

CONCLUSION

The transcriptional targets identified in this study should facilitate the formulation or refinement of useful molecular descriptors for diagnosis, prognosis, and therapy of breast cancer.

摘要

背景

孕激素受体(PR)由单个基因表达为两种异构体,即 PRA 和 PRB。在正常乳腺人类组织中,PRA 和 PRB 以等摩尔比例表达,但在恶性进展过程中,异构体比例发生改变,通常导致高 PRA:PRB 比值。我们利用一种 PRA 异构体占优势的转基因小鼠模型(PRA 转基因),并确定了与 PRA 转基因小鼠乳腺中癌前表型相关的关键转录事件和相关途径,与正常野生型同窝仔比较。

方法

使用微阵列技术生成 PRA 转基因和野生型乳腺的转录组图谱。我们鉴定了差异表达基因,并分析了聚类、基因本体论(GO)、基因集富集分析(GSEA)和途径图谱。我们还与人类乳腺癌的公开基因表达数据集进行了比较。

结果

我们鉴定了大量差异表达基因,这些基因主要与 PRA 转基因表型的代谢途径有关,而炎症相关途径呈负相关。此外,我们确定了表征 PRA 转基因的途径与乳腺癌亚型 Luminal A 和 Luminal B 的途径之间存在显著重叠,并鉴定了新的潜在生物标志物,如 PDHB 和 LAMB3。

结论

本研究中鉴定的转录靶标应有助于制定或完善用于乳腺癌诊断、预后和治疗的有用分子描述符。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa3/6019805/11e719629328/12885_2018_4550_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa3/6019805/2b49797c4dc4/12885_2018_4550_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa3/6019805/f781292c28d8/12885_2018_4550_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa3/6019805/9b584abfd9df/12885_2018_4550_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa3/6019805/77e444b06f82/12885_2018_4550_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa3/6019805/11e719629328/12885_2018_4550_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa3/6019805/2b49797c4dc4/12885_2018_4550_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa3/6019805/f781292c28d8/12885_2018_4550_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa3/6019805/9b584abfd9df/12885_2018_4550_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa3/6019805/77e444b06f82/12885_2018_4550_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1aa3/6019805/11e719629328/12885_2018_4550_Fig5_HTML.jpg

相似文献

1
Gene expression profile and cancer-associated pathways linked to progesterone receptor isoform a (PRA) predominance in transgenic mouse mammary glands.基因表达谱与癌症相关途径与孕激素受体异构体 A(PRA)在转基因小鼠乳腺中的优势相关。
BMC Cancer. 2018 Jun 25;18(1):682. doi: 10.1186/s12885-018-4550-z.
2
Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.孕激素受体亚型比例:一种乳腺癌抗孕激素反应性的预后及预测因子
J Natl Cancer Inst. 2017 Jul 1;109(7). doi: 10.1093/jnci/djw317.
3
Differential quantitative proteomics reveals key proteins related to phenotypic changes of breast cancer cells expressing progesterone receptor A.差异定量蛋白质组学揭示了与孕激素受体 A 表达的乳腺癌细胞表型变化相关的关键蛋白。
J Steroid Biochem Mol Biol. 2020 Apr;198:105560. doi: 10.1016/j.jsbmb.2019.105560. Epub 2019 Dec 3.
4
Loss of co-ordinate expression of progesterone receptors A and B is an early event in breast carcinogenesis.孕激素受体A和B的协同表达缺失是乳腺癌发生过程中的早期事件。
Breast Cancer Res Treat. 2002 Mar;72(2):163-72. doi: 10.1023/a:1014820500738.
5
Differential hormonal regulation and function of progesterone receptor isoforms in normal adult mouse mammary gland.成年正常小鼠乳腺中孕酮受体亚型的差异激素调节及功能
Endocrinology. 2007 May;148(5):2290-300. doi: 10.1210/en.2006-1721. Epub 2007 Feb 22.
6
The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer.PR-A 和 PR-B 转基因小鼠的增生表型:雌激素和孕激素受体在乳腺和乳腺癌中作用的启示。
Vitam Horm. 2013;93:185-201. doi: 10.1016/B978-0-12-416673-8.00012-5.
7
Progesterone receptor isoforms and proliferation in the rat mammary gland during development.大鼠乳腺发育过程中的孕激素受体亚型与增殖
Endocrinology. 2007 Jun;148(6):2723-36. doi: 10.1210/en.2006-1493. Epub 2007 Mar 1.
8
Progesterone receptor isoforms A and B: temporal and spatial differences in expression during murine mammary gland development.孕激素受体亚型A和B:小鼠乳腺发育过程中表达的时空差异
Endocrinology. 2005 Aug;146(8):3577-88. doi: 10.1210/en.2005-0346. Epub 2005 May 5.
9
Overlapping and distinct expression of progesterone receptors A and B in mouse uterus and mammary gland during the estrous cycle.动情周期中孕激素受体A和B在小鼠子宫和乳腺中的重叠与差异表达
Endocrinology. 2006 Dec;147(12):5503-12. doi: 10.1210/en.2006-0040. Epub 2006 Sep 15.
10
Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium.子宫内膜样子宫内膜癌中孕激素受体A和B的相对表达
Cancer Res. 2001 Jun 1;61(11):4576-82.

引用本文的文献

1
Progress in the research of cuproptosis and possible targets for cancer therapy.铜死亡的研究进展及癌症治疗的潜在靶点
World J Clin Oncol. 2023 Sep 24;14(9):324-334. doi: 10.5306/wjco.v14.i9.324.
2
A novel cuproptosis-related prognostic 2-lncRNAs signature in breast cancer.一种新的与铜死亡相关的乳腺癌预后双lncRNA特征
Front Pharmacol. 2023 Jan 9;13:1115608. doi: 10.3389/fphar.2022.1115608. eCollection 2022.
3
The Impact of Modifying Sunitinib Treatment Scheduling on Renal Cancer Tumor Biology and Resistance.改变舒尼替尼治疗方案对肾癌肿瘤生物学及耐药性的影响

本文引用的文献

1
Estrogen and progesterone signalling in the normal breast and its implications for cancer development.雌激素和孕激素在正常乳腺中的信号转导及其对癌症发展的影响。
Mol Cell Endocrinol. 2018 May 5;466:2-14. doi: 10.1016/j.mce.2017.08.011. Epub 2017 Aug 26.
2
Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.孕激素受体亚型比例:一种乳腺癌抗孕激素反应性的预后及预测因子
J Natl Cancer Inst. 2017 Jul 1;109(7). doi: 10.1093/jnci/djw317.
3
Transcriptomic dynamics of breast cancer progression in the MMTV-PyMT mouse model.
J Clin Med. 2022 Jan 13;11(2):369. doi: 10.3390/jcm11020369.
4
Alterations in Progesterone Receptor Isoform Balance in Normal and Neoplastic Breast Cells Modulates the Stem Cell Population.孕激素受体异构体平衡在正常和肿瘤乳腺细胞中的改变调节干细胞群体。
Cells. 2020 Sep 11;9(9):2074. doi: 10.3390/cells9092074.
5
EO771, the first luminal B mammary cancer cell line from C57BL/6 mice.EO771,首个源自C57BL/6小鼠的腔面B型乳腺癌细胞系。
Cancer Cell Int. 2020 Jul 20;20:328. doi: 10.1186/s12935-020-01418-1. eCollection 2020.
MMTV-PyMT小鼠模型中乳腺癌进展的转录组动力学
BMC Genomics. 2017 Feb 17;18(1):185. doi: 10.1186/s12864-017-3563-3.
4
Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients.利用1065例患者的转录组数据对胃癌生存相关生物标志物进行交叉验证。
Oncotarget. 2016 Aug 2;7(31):49322-49333. doi: 10.18632/oncotarget.10337.
5
The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes.2,433 例乳腺癌的体细胞突变图谱细化了其基因组和转录组景观。
Nat Commun. 2016 May 10;7:11479. doi: 10.1038/ncomms11479.
6
The Molecular Signatures Database (MSigDB) hallmark gene set collection.分子特征数据库(MSigDB)标志性基因集集合。
Cell Syst. 2015 Dec 23;1(6):417-425. doi: 10.1016/j.cels.2015.12.004.
7
Metabolic plasticity of metastatic breast cancer cells: adaptation to changes in the microenvironment.转移性乳腺癌细胞的代谢可塑性:对微环境变化的适应
Neoplasia. 2015 Aug;17(8):671-84. doi: 10.1016/j.neo.2015.08.005.
8
Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial.在ATAC试验中,孕激素受体A占优势是内分泌治疗获益的一个判别因素。
Breast Cancer Res Treat. 2015 Jun;151(2):309-18. doi: 10.1007/s10549-015-3397-0. Epub 2015 Apr 28.
9
Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters.乳腺癌中孕激素和抗孕激素反应性是由PRA/PRB比值通过AIB1或SMRT募集至CCND1和MYC启动子驱动的。
Int J Cancer. 2015 Jun 1;136(11):2680-92. doi: 10.1002/ijc.29304. Epub 2014 Nov 12.
10
Association of H3K9me3 and H3K27me3 repressive histone marks with breast cancer subtypes in the Nurses' Health Study.护士健康研究中H3K9me3和H3K27me3抑制性组蛋白标记与乳腺癌亚型的关联
Breast Cancer Res Treat. 2014 Oct;147(3):639-51. doi: 10.1007/s10549-014-3089-1. Epub 2014 Sep 16.